ALBO insider filings
ALBIREO PHARMA, INC. — 15 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-03. Screen ALBO transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ALBO between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — ALBIREO PHARMA, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-03-03 | 4 | Chiswell David — Director | Code (U): 56,278 · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 5,500 (derivative) · +2 more | EDGAR |
| 2023-03-02 | 4 | Alesina Susan — Director | Disposition to issuer (D): 16,000 (derivative) | EDGAR |
| 2023-03-02 | 4 | Okey Stephanie — Director | Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 11,000 (derivative) | EDGAR |
| 2023-03-02 | 4 | Harford Simon N.R. — CFO and Treasurer | Code (U): 13,739 · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 73,950 (derivative) | EDGAR |
| 2023-03-02 | 4 | Cooper Ronald Harold Wilfred — President and CEO, Director | Code (U): 33,094 · Disposition to issuer (D): 132,150 (derivative) · Disposition to issuer (D): 43,027 (derivative) · Disposition to issuer (D): 93,000 (derivative) · Disposition to issuer (D): 124,000 (derivative) · Disposition to issuer (D): 124,000 (derivative) · +5 more | EDGAR |
| 2023-03-02 | 4 | STRECK PAUL — Chief Medical Officer | Disposition to issuer (D): 118,966 (derivative) | EDGAR |
| 2023-03-02 | 4 | Stephenson Pamela — Chief Commercial Officer | Code (U): 22,242 · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 75,513 (derivative) | EDGAR |
| 2023-03-02 | 4 | Graham Michelle — Chief Human Resources Officer | Code (U): 5,543 · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 50,950 (derivative) | EDGAR |
| 2023-03-02 | 4 | Gutch Michael — Director | Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 3,000 (derivative) · +1 more | EDGAR |
| 2023-03-02 | 4 | Duncan Jason — Chief Legal Officer and GC | Code (U): 3,296 · Disposition to issuer (D): 15,900 (derivative) · Disposition to issuer (D): 10,063 (derivative) · Disposition to issuer (D): 24,337 (derivative) · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 37,500 (derivative) · +1 more | EDGAR |
| 2023-03-02 | 4 | Mattsson Jan — Chief Scientific Officer | Code (U): 35,524 · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 13,000 (derivative) · +2 more | EDGAR |
| 2023-03-02 | 4 | Dable Habib J — Director | Disposition to issuer (D): 16,000 (derivative) | EDGAR |
| 2023-03-02 | 4 | Hopkinson Craig C. — Director | Disposition to issuer (D): 10,495 (derivative) | EDGAR |
| 2023-03-02 | 4 | SCOON DAVEY — Director | Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 5,500 (derivative) · Disposition to issuer (D): 3,000 (derivative) · +3 more | EDGAR |
| 2023-03-02 | 4 | Carter Martha J. — Chief Regulatory Officer | Code (U): 3,656 · Disposition to issuer (D): 15,900 (derivative) · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 3,250 (derivative) · Disposition to issuer (D): 62,009 (derivative) · Disposition to issuer (D): 2,500 (derivative) · +4 more | EDGAR |
Recent 8-K events — ALBIREO PHARMA, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-03-02 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-02-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALBO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →